Gouvernance Roche Holding AG

ROG

CH0012032048

Produits pharmaceutiques

Marché Fermé - Swiss Exchange Autres places de cotation 17:30:33 15/05/2025			Varia. 5j.	Varia. 1 janv.
257,00 ^CHF	+0,98%		-1,12%	+0,59%

13:40	Les entreprises étrangères envisagent de s'implanter aux États-Unis pour atténuer les effets des droits de douane	RE
11:16	Roche : a reçu une approbation de la FDA pour le cancer	CF

Comité Exécutif: Roche Holding AG

Dirigeant

Fonctions occupéesDepuis

Thomas Schinecker

50 ans

Chief Executive Officer

15/03/2023

Alan Hippe

58 ans

Director of Finance/CFO

06/06/2011

Levi Garraway

57 ans

Chief Tech/Sci/R&D Officer

01/01/2023

Pascale Schmidt

52 ans

Compliance Officer

01/01/2020

Claudia Boeckstiegel

61 ans

General Counsel

01/04/2020

Cristina Wilbur

58 ans

Human Resources Officer

Bruno Eschli

Investor Relations Contact

01/08/2014

Per-Olof Attinger

65 ans

Corporate Secretary

Wafaa Mamilli

58 ans

Chief Tech/Sci/R&D Officer

10/02/2025

Composition du Conseil d'Administration: Roche Holding AG

Administrateur

ComitésDepuis

Severin Schwan

58 ans

Chairman

15/03/2023

André Hoffmann

67 ans

Governance Committee	01/01/1996
Nominating Committee	01/01/1996
Compensation Committee Chair	01/01/1996
Compensation Committee	01/01/1996
Governance Committee Chair	01/01/1996

Claudia Dyckerhoff

58 ans

Audit Committee	01/03/2016
Governance Committee	01/03/2016
Compensation Committee	21/04/2016

Anita Hauser

56 ans

Compensation Committee	14/03/2017
Nominating Committee	14/03/2017

Joerg Duschmale

41 ans

Audit Committee	17/03/2020
Compensation Committee Chair	17/03/2020

Ulf Mark Schneider

60 ans

Audit Committee	01/03/2023
Governance Committee	01/10/2014

Jemilah Mahmood

66 ans

Governance Committee

01/03/2022

Akiko Iwasaki

55 ans

Governance Committee

01/03/2023

Patrick Frost

57 ans

Audit Committee Chair

17/03/2020

Richard P. Lifton

72 ans

Director/Board Member	03/03/2015
Independent Dir/Board Member	03/03/2015

Dernières Nominations: Roche Holding AG

Roche annonce des changements au niveau de la direction	20/03	CI
Solvonis Therapeutics plc nomme le Dr. Renata Crome au poste d'administrateur non exécutif indépendant	11/03	CI
Claudia Bockstiegel et Nathalie Rachou ne se représentent pas UBS Group Ag en tant que membre du Conseil d'administration	04/03	CI
Roche annonce des changements au niveau de la direction et du comité	29/01	CI
Roche : nomination d'une CDTO	29/01	CF
BioXcel Therapeutics, Inc. nomme Rajiv Patni au conseil d'administration	16/01	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Roche Holding AG

Insider

Fonctions occupées

DepuisJusqu'au

Christoph Franz

Chairman	01/03/2014	15/03/2023
Independent Dir/Board Member	01/03/2014	15/03/2023

Nicolas Dunant

Public Communications Contact

01/02/2019

01/05/2022

William Pao

Corporate Officer/Principal

01/05/2014

18/03/2022

Paul Bulcke

Director/Board Member	06/06/2011	01/01/2022
Independent Dir/Board Member	06/09/2011	15/03/2012

Gottlieb A. Keller

General Counsel	13/01/2010	31/03/2020
Corporate Secretary	01/01/2008	31/03/2020

John Bell

Director/Board Member	17/09/2009	17/03/2020
Independent Dir/Board Member	01/04/2011	12/09/2011
Corporate Officer/Principal	01/01/2001	17/09/2009

Andreas Oeri

Director/Board Member	13/01/2010	17/03/2020
Independent Dir/Board Member	06/09/2011	17/03/2020
Corporate Officer/Principal	01/01/1996	13/01/2010

Stephan Feldhaus

Public Communications Contact

08/09/2010

30/09/2019

Peter Voser

Director/Board Member	01/02/2011	30/06/2019
Independent Dir/Board Member	06/09/2011	15/03/2012

John Reed

Corporate Officer/Principal

02/04/2013

02/04/2018

Roland Diggelmann

Corporate Officer/Principal

01/01/2012

01/01/2018

Pius Baschera

Director/Board Member	13/01/2010	31/03/2017
Independent Dir/Board Member	06/09/2011	12/09/2011

DeAnne Shirley Julius

Director/Board Member	13/01/2010	01/03/2016
Independent Dir/Board Member	06/09/2011	01/03/2016
Corporate Officer/Principal	01/01/2002	13/01/2010

Beatrice Weder di Mauro

Director/Board Member	13/01/2010	01/03/2016
Independent Dir/Board Member	29/07/2011	12/09/2011

Silvia Ayyoubi

Human Resources Officer

13/01/2010

31/12/2015

Bernard Poussot

Director/Board Member	03/03/2015	-
Independent Dir/Board Member	03/03/2015	-

Hyam Levitsky

Corporate Officer/Principal

01/08/2011

01/02/2015

Michael Varney

Corporate Officer/Principal

01/01/2015

Richard Scheller

Corporate Officer/Principal

01/01/2009

31/12/2014

William Burns

Director/Board Member	01/03/2010	04/03/2014
Independent Dir/Board Member	01/03/2010	15/03/2012

Franz Humer

Chairman

06/09/2011

04/03/2014

Lodewijk J. R. de Vink

Director/Board Member	13/01/2010	05/03/2013
Independent Dir/Board Member	11/04/2011	12/09/2011
Corporate Officer/Principal	01/01/2004	13/01/2010

Bruno Gehrig

Director/Board Member	01/01/2004	05/03/2013
Independent Dir/Board Member	01/01/2004	15/03/2012

Jean-Jacques Garaud

Corporate Officer/Principal

01/01/2007

30/06/2012

Klaus Gustav Strein

Corporate Officer/Principal

14/09/2011

Erich Hunziker

Director/Board Member	18/01/2011	18/01/2011
Chief Tech/Sci/R&D Officer	13/01/2010	31/03/2011
Director of Finance/CFO	01/10/2001	31/03/2011

Wolfgang Ruttenstorfer

Director/Board Member	13/01/2010	14/12/2010
Independent Dir/Board Member	01/01/2007	01/01/2011

Walter Frey

Director/Board Member	13/01/2010	14/12/2010
Independent Dir/Board Member	01/01/2001	01/01/2011
Corporate Officer/Principal	01/01/2001	13/01/2010

David M. Goldstein

Corporate Officer/Principal

01/01/1994

01/01/2011

Peter Brabeck-Letmathe

Director/Board Member

01/03/2010

Arthur Levinson

Director/Board Member	01/03/2010	-
Independent Dir/Board Member	26/04/2011	12/09/2011

Eduard Enrico Holdener

Corporate Officer/Principal

01/01/1995

01/01/2007

Michael Burgess

Corporate Officer/Principal

24/10/2011

Rolf Hänggi

Director/Board Member

01/01/2006

Dirk W. Kirsten

Corporate Officer/Principal

01/01/2002

01/01/2004

Domenico Scala

Corporate Officer/Principal	01/01/1995	01/01/2000
Treasurer	01/01/2000	01/01/2003

Henri-Paul Meier

Investor Relations Contact	09/09/2011	-
Public Communications Contact	15/03/2002	-

Horst Teltschik

Director/Board Member	13/01/2010	-
Corporate Officer/Principal	01/01/2002	13/01/2010

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

01/01/1978

Vincent Charlon

Corporate Officer/Principal

01/01/1990

01/01/1998

Rolf Schläpfer

Public Communications Contact

01/01/1997

Unni Hjelmaas

Corporate Officer/Principal

01/01/1997

Gerard Farmer

General Counsel

01/01/1989

Pierre Jaccoud

Corporate Secretary

01/01/1988

Marc Salzberg

Corporate Officer/Principal

Wing-Kai Chan

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Markus Hosang

Corporate Officer/Principal

Daniel O'Day

Corporate Officer/Principal

Eva Losert

Public Communications Contact

Simon Roitt

Corporate Officer/Principal

Ivan Melezínek

Corporate Officer/Principal

Ashok Dhanrajgir

Corporate Officer/Principal

Melanie Wolf

Public Communications Contact

Kuno Sommer

Corporate Officer/Principal

Alexander Klauser

Public Communications Contact

08/09/2010

Ann Moravick

Corporate Officer/Principal

Peter Johann

Sales & Marketing

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Andreas Emmenegger

Corporate Officer/Principal

Dámaso Molero

Corporate Officer/Principal

Andreas Greuter

General Counsel

Urs Jaisli

Compliance Officer

31/01/2013

Jean-Pierre Obrecht

Corporate Officer/Principal

Tim George

Sales & Marketing

Ken A. Brameld

Corporate Officer/Principal

Alexander Zehnder

Corporate Officer/Principal

Stefan Ryser

Human Resources Officer

Robert Salcedo

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Fritz Hoffmann-la Roche

Founder

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	17
Femme	8

Dont comité exécutif

Homme	5
Femme	4

Dont Administrateurs

Homme	9
Femme	1

Révisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

ESG

ESG : Environnement

ESG : Social

ESG : Gouvernance

ESG : Polémique

ESG : Controverses Ethiques

ESG : Controverses sur les droits de l'Homme

ESG : Controverses Subventions fiscales

ESG : Conforme à la finance Islamique

Roche Holding AG (Roche) est une entreprise de recherche dans le domaine de la santé. Les activités opérationnelles de la société sont organisées en deux divisions : Pharmaceuticals et Diagnostics. La division pharmaceutique se compose de deux secteurs d'activité : Roche Pharmaceuticals et Chugai. La division Diagnostics se compose de quatre secteurs d'activité : Diabetes Care, Molecular Diagnostics, Professional Diagnostics et Tissue Diagnostics. La société développe des médicaments pour divers domaines pathologiques, notamment l'oncologie, l'immunologie, les maladies infectieuses, l'ophtalmologie et les neurosciences. Ses produits pharmaceutiques comprennent Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin et Roferon-A. La société propose des produits pour les chercheurs, notamment pour l'analyse cellulaire, l'expression génétique, le séquençage du génome et la purification des acides nucléiques.

Employés

103 249

Secteur

Produits pharmaceutiques

Agenda

17:00 - Bank of America Global Healthcare Conference

Plus d'informations sur la société